Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study

Multiple Sclerosis Clinical Trial

Official title:

Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00343590
• Other study ID #: LCC-06-03
• Status: Completed
• Phase: N/A
• First received: June 21, 2006
• Last updated: October 16, 2008
• Start date: June 2006
• Est. completion date: November 2006

Study information

• Verified date: October 2008
• Source: Logan College of Chiropractic
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this investigation is to determine the effect of Whole Body Vibration Therapy (WBV) on balance in a participant with multiple sclerosis (MS) related balance deficits as measured by the NeuroCom Balance Master, the Sapphire IIME EMG Device and the Kurtzke Expanded Disability Status Scale (EDSS) and the Berg Balance Score.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: November 2006
• Est. primary completion date: November 2006
• Gender: Both
• Age group: 25 Years to 65 Years

Eligibility

Inclusion Criteria:

Logan student, staff, or faculty or general public with a minimal of 2 year history of diagnosed Multiple Sclerosis (MS)

Exclusion Criteria:

1)visual or vestibular condition that would affect balance; 2) Non-Ms related systemic illness that would have an adverse effect on balance; 3) Local infection, acute inflammation, injury, tumors or other malignancy, recent wounds, diabetes; 4) Any unstable joints of the lower extremity, recent hip and knee joints or fitted hip or knee pins, bolts and/or plates; 5) Acute thrombosis; 6) Severe migraine, epilepsy; 7) Serious cardiovascular disease, wearing a pacemaker; Any Spinal manipulation within 48 hours; 8) Acute disc herniation, discopathy or spondylolysis; 9) Prescription or herbal muscle stimulants, relaxants, etc. that could affect balance; 10) Any implanted device or prosthesis or intrauterine IUD type of device; 11) Pregnancy

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Multiple Sclerosis
• Sclerosis

Intervention

Device:
• Whole Body Vibration machine

Locations

Country	Name	City	State
United States	Logan College of Chiropractic	Chesterfield	Missouri
United States	Logan College of Chirpractic	Chesterfield	Missouri

Sponsors (1)

Lead Sponsor	Collaborator
Logan College of Chiropractic

Country where clinical trial is conducted

United States, 

References & Publications (2)

Griffin JW. Use of proprioceptive stimuli in therapeutic exercise. Phys Ther. 1974 Oct;54(10):1072-9. — View Citation

Romberg A, Virtanen A, Ruutiainen J, Aunola S, Karppi SL, Vaara M, Surakka J, Pohjolainen T, Seppänen A. Effects of a 6-month exercise program on patients with multiple sclerosis: a randomized study. Neurology. 2004 Dec 14;63(11):2034-8. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	NeuroCom Balance Master
Primary	SF-EMG Nerve conduction velocity test
Primary	Berg balance score